RMD.AX
RMD.AX
AU000000RMD6
RESMED CDI 10:1 [RMD]
Loading chart...

Company Profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Related stocks

RMD
RMD • United States
ResMed Inc.
230.05 USD
32.35B USD 1Y -19.7%
MDLN
MDLN • United States
Medline Inc.
36.26 USD
48.79B USD
WST
WST • United States
West Pharmaceutical Services, I
366 USD
25.76B USD 1Y +35.6%
SOLV
SOLV • United States
Solventum Corporation
87.29 USD
14.86B USD 1Y +19.3%
BAX
BAX • United States
Baxter International Inc.
24.35 USD
12.59B USD 1Y +5.1%
BDX
BDX • United States
Becton, Dickinson and Company
183.75 USD
50.05B USD 1Y +19.9%
COO
COO • United States
The Cooper Companies, Inc.
54.37 USD
10.34B USD 1Y -22.7%
AVTR
AVTR • United States
Avantor, Inc.
15.67 USD
10.6B USD 1Y +11.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.0% p.a.
Max Drawdown (5Y)
-43.0%
Sharpe Ratio (5Y)
-0.14
Beta Factor
0.75
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Historical Stress Test: Maximum peak-to-trough drawdown of -47.0% in the extended horizon.
ende